...
首页> 外文期刊>Mutagenesis >The in vivo comet assay: use and status in genotoxicity testing.
【24h】

The in vivo comet assay: use and status in genotoxicity testing.

机译:体内彗星试验:在遗传毒性试验中的用途和状态。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The in vivo comet assay (single cell gel electrophoresis assay) in its alkaline version (pH >13) is being increasingly used in genotoxicity testing of substances such as industrial chemicals, biocides, agrochemicals, food additives and pharmaceuticals. Recommendations for an appropriate performance of the test using OECD guidelines for other in vivo genotoxicity tests have been published. In this review, we critically discuss the biological significance of comet assay effects in general and the status of the test in current strategies for genotoxicity testing. Examples for practical applications of the in vivo comet assay and potential consequences of positive and negative test results are given. The significance of comet assay results for hazard identification and risk assessment is discussed. In accordance with international guidelines for genotoxicity testing the in vivo comet assay is recommended for follow-up testing of positive in vitro findings. It is particularly useful as a tool for the evaluation of local genotoxicity, especially for organs/cell types which cannot easily be evaluated with other standard tests. A positive result in an appropriately performed in vivo comet assay indicates genotoxicity of the test compound in the tissue tested and gains particular significance when a mutagenic potential of the test compound has already been demonstrated in vitro. Such findings will have practical consequences in the risk assessment processes and further development of substances.
机译:碱性形式(pH> 13)的体内彗星试验(单细胞凝胶电泳试验)正越来越多地用于物质的遗传毒性测试,例如工业化学品,杀生物剂,农用化学品,食品添加剂和药品。已经发布了使用OECD指南进行其他体内基因毒性测试的适当测试性能的建议。在这篇综述中,我们批判性地讨论了彗星试验作用的生物学意义,以及当前遗传毒性试验策略中试验的地位。给出了体内彗星试验的实际应用示例以及阳性和阴性测试结果的潜在后果。讨论了彗星测定结果对危险识别和风险评估的意义。根据遗传毒性测试的国际准则,建议对体内阳性结果进行后续测试以进行体内彗星试验。它特别适合用作评估局部遗传毒性的工具,尤其是对于其他标准测试无法轻易评估的器官/细胞类型。适当进行的体内彗星试验的阳性结果表明受试化合物在受试组织中具有遗传毒性,当已经在体外证明了受试化合物的诱变潜力时,其具有特别的意义。这些发现将对风险评估过程和物质的进一步开发产生实际影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号